Mirati Therapeutics, Inc. (MRTX)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
23-Jan-24 8:37 PM
View: 
Sandler Alan B.
Chief Medical Officer
Mirati Therapeutics, Inc. (MRTX) 23-Jan-24Disposition 79,865----(100%)
79.86K to 0
23-Jan-24 8:38 PM
View: 
Cherrington Julie M
Director
Mirati Therapeutics, Inc. (MRTX) 23-Jan-24Disposition 11,252----(100%)
11.25K to 0
23-Jan-24 8:37 PM
View: 
Moriarty John B
Chief Legal Officer
Mirati Therapeutics, Inc. (MRTX) 23-Jan-24Disposition 72,335----(100%)
72.33K to 0
25-Jan-24 4:32 PM
View: 
Boxer Capital, LLC
Mirati Therapeutics, Inc. (MRTX) 23-Jan-24Disposition 3,370,240----(100%)
3.37M to 0
23-Jan-24 8:37 PM
View: 
Ondrey Aaron
Chief Financial Officer
Mirati Therapeutics, Inc. (MRTX) 23-Jan-24Disposition 39,461----(100%)
39.46K to 0
23-Jan-24 8:37 PM
View: 
Gallagher Carol Giltner
Director
Mirati Therapeutics, Inc. (MRTX) 23-Jan-24Disposition 14,363----(100%)
14.36K to 0
23-Jan-24 8:37 PM
View: 
Johnson Craig A
Director
Mirati Therapeutics, Inc. (MRTX) 23-Jan-24Disposition 17,273----(100%)
17.27K to 0
23-Jan-24 8:37 PM
View: 
Hickey Benjamin
EVP, Chief Commercial Officer
Mirati Therapeutics, Inc. (MRTX) 23-Jan-24Disposition 117,028----(100%)
117.03K to 0
25-Jan-24 4:32 PM
View: 
Boxer Capital, LLC
Mirati Therapeutics, Inc. (MRTX) 23-Jan-24Disposition 287,866----(4%)
6.86M to 6.57M
23-Jan-24 8:38 PM
View: 
Davis Aaron I.
Director
Mirati Therapeutics, Inc. (MRTX) 23-Jan-24Disposition 54,325----(100%)
54.33K to 0
23-Jan-24 8:37 PM
View: 
Christensen Jamie
EVP & Chief Scientific Officer
Mirati Therapeutics, Inc. (MRTX) 23-Jan-24Disposition 154,996----(100%)
155.0K to 0
23-Jan-24 8:37 PM
View: 
Martinez Maria E
Director
Mirati Therapeutics, Inc. (MRTX) 23-Jan-24Disposition 17,273----(100%)
17.27K to 0
23-Jan-24 8:38 PM
View: 
Sharp Shalini
Director
Mirati Therapeutics, Inc. (MRTX) 23-Jan-24Disposition 16,222----(100%)
16.22K to 0
25-Jan-24 4:32 PM
View: 
Boxer Capital, LLC
Mirati Therapeutics, Inc. (MRTX) 23-Jan-24Disposition 3,201,440----(49%)
6.57M to 3.37M
23-Jan-24 8:37 PM
View: 
Hasnain Faheem
Director
Mirati Therapeutics, Inc. (MRTX) 23-Jan-24Disposition 24,752----(100%)
24.75K to 0
23-Jan-24 8:37 PM
View: 
Carter Bruce L A
Director
Mirati Therapeutics, Inc. (MRTX) 23-Jan-24Disposition 17,273----(100%)
17.27K to 0
23-Jan-24 8:37 PM
View: 
Baum Charles M
Founder, President, and CEO
Director
Mirati Therapeutics, Inc. (MRTX) 23-Jan-24Disposition 237,871----(100%)
237.87K to 0
18-Jan-24 4:45 PM
View: 
Hickey Benjamin
EVP, Chief Commercial Officer
Mirati Therapeutics, Inc. (MRTX) 16-Jan-24Sale 1,597$59.02$94,254.90(1%)
118.63K to 117.03K
18-Jan-24 4:38 PM
View: 
Christensen Jamie
EVP & Chief Scientific Officer
Mirati Therapeutics, Inc. (MRTX) 16-Jan-24Sale 1,597$59.02$94,254.90(1%)
157.52K to 155.93K
09-Jan-24 5:54 PM
View: 
Hickey Benjamin
EVP, Chief Commercial Officer
Mirati Therapeutics, Inc. (MRTX) 08-Jan-24Sale 2,090$58.92$123,143.00(2%)
120.72K to 118.63K
05-Jan-24 5:34 PM
View: 
Christensen Jamie
EVP & Chief Scientific Officer
Mirati Therapeutics, Inc. (MRTX) 04-Jan-24Sale 1,531$58.81$90,038.10(< 1%)
158.67K to 157.13K
03-Jan-24 6:27 PM
View: 
Gallagher Carol Giltner
Director
Mirati Therapeutics, Inc. (MRTX) 29-Dec-23Grant 6,808$58.75$399,970.0090%
7.55K to 14.36K
03-Jan-24 6:37 PM
View: 
Johnson Craig A
Director
Mirati Therapeutics, Inc. (MRTX) 29-Dec-23Grant 6,808$58.75$399,970.0065%
10.46K to 17.27K
03-Jan-24 6:13 PM
View: 
Hickey Benjamin
EVP, Chief Commercial Officer
Mirati Therapeutics, Inc. (MRTX) 29-Dec-23Grant 17,021$58.75$999,984.0016%
103.69K to 120.72K
03-Jan-24 8:50 PM
View: 
Davis Aaron I.
Director
Mirati Therapeutics, Inc. (MRTX) 29-Dec-23Grant 6,808$58.75$399,970.0014%
47.52K to 54.33K
03-Jan-24 6:05 PM
View: 
Christensen Jamie
EVP & Chief Scientific Officer
Mirati Therapeutics, Inc. (MRTX) 29-Dec-23Grant 17,021$58.75$999,984.0012%
141.65K to 158.67K
03-Jan-24 6:32 PM
View: 
Martinez Maria E
Director
Mirati Therapeutics, Inc. (MRTX) 29-Dec-23Grant 6,808$58.75$399,970.0065%
10.46K to 17.27K
03-Jan-24 6:24 PM
View: 
Sharp Shalini
Director
Mirati Therapeutics, Inc. (MRTX) 29-Dec-23Grant 6,808$58.75$399,970.0072%
9.41K to 16.22K
03-Jan-24 6:18 PM
View: 
Hasnain Faheem
Director
Mirati Therapeutics, Inc. (MRTX) 29-Dec-23Grant 9,702$58.75$569,992.0064%
15.05K to 24.75K
03-Jan-24 6:16 PM
View: 
Carter Bruce L A
Director
Mirati Therapeutics, Inc. (MRTX) 29-Dec-23Grant 6,808$58.75$399,970.0065%
10.46K to 17.27K
03-Jan-24 6:01 PM
View: 
Sandler Alan B.
Chief Medical Officer
Mirati Therapeutics, Inc. (MRTX) 29-Dec-23Grant 17,021$58.75$999,984.0027%
62.3K to 79.32K
03-Jan-24 6:22 PM
View: 
Cherrington Julie M
Director
Mirati Therapeutics, Inc. (MRTX) 29-Dec-23Grant 6,808$58.75$399,970.00153%
4.44K to 11.25K
03-Jan-24 5:52 PM
View: 
Baum Charles M
Interim CEO
Director
Mirati Therapeutics, Inc. (MRTX) 29-Dec-23Grant 20,425$58.75$1,199,970.009%
227.28K to 247.7K
03-Jan-24 5:55 PM
View: 
Ondrey Aaron
CFO
Mirati Therapeutics, Inc. (MRTX) 29-Dec-23Grant 17,021$58.75$999,984.0076%
22.44K to 39.46K
19-Dec-23 4:59 PM
View: 
Christensen Jamie
EVP & Chief Scientific Officer
Mirati Therapeutics, Inc. (MRTX) 18-Dec-23Sale 2,387$57.50$137,252.00(2%)
144.03K to 141.65K
14-Dec-23 5:05 PM
View: 
Hickey Benjamin
EVP, Chief Commercial Officer
Mirati Therapeutics, Inc. (MRTX) 13-Dec-23Sale 2,220$56.67$125,807.00(2%)
105.91K to 103.69K
12-Sep-23 5:41 PM
View: 
Christensen Jamie
EVP & Chief Scientific Officer
Mirati Therapeutics, Inc. (MRTX) 08-Sep-23Sale 2,388$35.63$85,084.40(2%)
146.42K to 144.03K
12-Sep-23 5:30 PM
View: 
Ondrey Aaron
Interim CFO
Mirati Therapeutics, Inc. (MRTX) 08-Sep-23Grant 8,412$35.66$299,972.0060%
14.03K to 22.44K
15-Aug-23 9:38 PM
View: 
Boxer Capital, LLC
Mirati Therapeutics, Inc. (MRTX) 11-Aug-23Private Purchase 57,533$27.80$1,599,420.001%
5.41M to 5.47M
15-Aug-23 9:39 PM
View: 
Boxer Capital, LLC
Mirati Therapeutics, Inc. (MRTX) 11-Aug-23Purchase
Duplicate
1,201,440$27.80$33,400,000.0022%
5.47M to 6.67M
14-Aug-23 4:41 PM
View: 
Hasnain Faheem
Director
Mirati Therapeutics, Inc. (MRTX) 11-Aug-23Private Purchase 10,791$27.80$299,990.0072%
15.05K to 25.84K
15-Aug-23 9:38 PM
View: 
Boxer Capital, LLC
Mirati Therapeutics, Inc. (MRTX) 11-Aug-23Purchase 1,201,440$27.80$33,400,000.0022%
5.47M to 6.67M
15-Aug-23 9:39 PM
View: 
Boxer Capital, LLC
Mirati Therapeutics, Inc. (MRTX) 11-Aug-23Private Purchase
Duplicate
57,533$27.80$1,599,420.001%
5.41M to 5.47M
10-Aug-23 4:26 PM
View: 
Stelzer Laurie
Chief Financial Officer
Mirati Therapeutics, Inc. (MRTX) 09-Aug-23Grant 22,297$37.00$824,989.0028%
80.02K to 102.31K
10-Aug-23 4:19 PM
View: 
Sandler Alan B.
Chief Medical Officer
Mirati Therapeutics, Inc. (MRTX) 09-Aug-23Grant 22,297$37.00$824,989.0056%
40.0K to 62.3K
10-Aug-23 4:21 PM
View: 
Christensen Jamie
EVP & Chief Scientific Officer
Mirati Therapeutics, Inc. (MRTX) 09-Aug-23Grant 22,297$37.00$824,989.0018%
124.12K to 146.42K
10-Aug-23 4:24 PM
View: 
Baum Charles M
Interim CEO
Director
Mirati Therapeutics, Inc. (MRTX) 09-Aug-23Grant 54,054$37.00$2,000,000.0031%
173.22K to 227.28K
10-Aug-23 4:23 PM
View: 
Hickey Benjamin
EVP, Chief Commercial Officer
Mirati Therapeutics, Inc. (MRTX) 09-Aug-23Grant 22,297$37.00$824,989.0027%
83.62K to 105.91K
10-Aug-23 4:22 PM
View: 
Moriarty John B
Chief Legal Officer
Mirati Therapeutics, Inc. (MRTX) 09-Aug-23Grant 22,297$37.00$824,989.0045%
49.36K to 71.66K
23-Jun-23 5:18 PM
View: 
Gallagher Carol Giltner
Director
Mirati Therapeutics, Inc. (MRTX) 22-Jun-23Grant 7,555----100%
0 to 7.55K